Jacob N Miller1, Donald W Black2. 1. University of Iowa Hospitals and Clinics, Iowa City, IA, 52242, USA. 2. Department of Psychiatry, University of Iowa Roy J. and Lucille A. Carver College of Medicine, 2-126b Medical Education Building, Iowa City, IA, 52242, USA. donald-black@uiowa.edu.
Abstract
PURPOSE OF REVIEW: Bipolar disorder has the highest rate of suicide of all psychiatric conditions and is approximately 20-30 times that of the general population. The purpose of this review is to discuss findings relevant to bipolar disorder and suicide. RECENT FINDINGS: Risk factors include male gender, living alone, divorced, no children, Caucasian, younger age (< 35 years), elderly age (> 75 years), unemployment, and a personal history of suicide attempt and family history of suicide attempt or suicide completion, as well as predominant depressive polarity. Suicide is associated with the depressed or mixed subtypes, not mania. Although there are emerging treatments for bipolar depression, such as ketamine and TMS, lithium remains the only medication associated with lowered suicide rates in bipolar disorder. Understanding clinical and demographic risk factors for suicide in bipolar disorder remains the best way to prevent suicidal behavior. Early intervention and treatment with anti-suicidal medications, such as lithium, along with close observation and follow-up is the best way to mitigate suicide in patients with bipolar disorder.
PURPOSE OF REVIEW: Bipolar disorder has the highest rate of suicide of all psychiatric conditions and is approximately 20-30 times that of the general population. The purpose of this review is to discuss findings relevant to bipolar disorder and suicide. RECENT FINDINGS: Risk factors include male gender, living alone, divorced, no children, Caucasian, younger age (< 35 years), elderly age (> 75 years), unemployment, and a personal history of suicide attempt and family history of suicide attempt or suicide completion, as well as predominant depressive polarity. Suicide is associated with the depressed or mixed subtypes, not mania. Although there are emerging treatments for bipolar depression, such as ketamine and TMS, lithium remains the only medication associated with lowered suicide rates in bipolar disorder. Understanding clinical and demographic risk factors for suicide in bipolar disorder remains the best way to prevent suicidal behavior. Early intervention and treatment with anti-suicidal medications, such as lithium, along with close observation and follow-up is the best way to mitigate suicide in patients with bipolar disorder.
Authors: R J Baldessarini; J Undurraga; G H Vázquez; L Tondo; P Salvatore; K Ha; H-M K Khalsa; B Lepri; T H Ha; J S Chang; M Tohen; E Vieta Journal: Acta Psychiatr Scand Date: 2011-12-21 Impact factor: 6.392
Authors: Jie Song; Arvid Sjölander; Erik Joas; Sarah E Bergen; Bo Runeson; Henrik Larsson; Mikael Landén; Paul Lichtenstein Journal: Am J Psychiatry Date: 2017-06-09 Impact factor: 18.112
Authors: Masoud Kamali; Erika F H Saunders; Alan R Prossin; Christine B Brucksch; Gloria J Harrington; Scott A Langenecker; Melvin G McInnis Journal: J Affect Disord Date: 2011-12-10 Impact factor: 4.839
Authors: Kathleen R Merikangas; Hagop S Akiskal; Jules Angst; Paul E Greenberg; Robert M A Hirschfeld; Maria Petukhova; Ronald C Kessler Journal: Arch Gen Psychiatry Date: 2007-05
Authors: Maurizio Pompili; Marco Innamorati; J John Mann; Maria A Oquendo; David Lester; Antonio Del Casale; Gianluca Serafini; Silvia Rigucci; Andrea Romano; Antonino Tamburello; Giovanni Manfredi; Eleonora De Pisa; Stefan Ehrlich; Giancarlo Giupponi; Mario Amore; Roberto Tatarelli; Paolo Girardi Journal: Prog Neuropsychopharmacol Biol Psychiatry Date: 2008-05-20 Impact factor: 5.067
Authors: Maurizio Pompili; Stefan Ehrlich; Eleonora De Pisa; J John Mann; Marco Innamorati; Andrea Cittadini; Benedetta Montagna; Paolo Iliceto; Andrea Romano; Mario Amore; Roberto Tatarelli; Paolo Girardi Journal: Eur Arch Psychiatry Clin Neurosci Date: 2007-09-27 Impact factor: 5.270
Authors: Elena Aragno; Andrea Fagiolini; Alessandro Cuomo; Elena Paschetta; Giuseppe Maina; Gianluca Rosso Journal: Arch Womens Ment Health Date: 2022-03-02 Impact factor: 3.633
Authors: Taise Possamai-Della; Gustavo C Dal-Pont; Wilson R Resende; Jorge M Aguiar-Geraldo; Jefté Peper-Nascimento; João Quevedo; Samira S Valvassori Journal: Mol Neurobiol Date: 2022-09-19 Impact factor: 5.682
Authors: Maria Alice Brito; Ali Amad; Benjamin Rolland; Pierre A Geoffroy; Hugo Peyre; Jean-Luc Roelandt; Imane Benradia; Pierre Thomas; Guillaume Vaiva; Franck Schürhoff; Baptiste Pignon Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-02-10 Impact factor: 5.270
Authors: Eric T Monson; Andrey A Shabalin; Anna R Docherty; Emily DiBlasi; Amanda V Bakian; Qingqin S Li; Douglas Gray; Brooks Keeshin; Sheila E Crowell; Niamh Mullins; Virginia L Willour; Hilary Coon Journal: Transl Psychiatry Date: 2021-07-07 Impact factor: 6.222